Unnatural Products Appoints Abbas Kazimi and Mert Aktar to Board of Directors Unnatural Products Appoints Abbas Kazimi and Mert Aktar to Board of Directors

Unnatural Products Announces BridgeBio Exercises Option to License Macrocyclic Therapeutics for Development in Rare Diseases and Oncology Unnatural Products Announces BridgeBio Exercises Option to License Macrocyclic Therapeutics for Development in Rare Diseases and Oncology

Unnatural Products Appoints Simon Bailey, Ph.D., as Chief Operating Officer and President of R&D Unnatural Products Appoints Simon Bailey, Ph.D., as Chief Operating Officer and President of R&D